Ilonov develops first-in-class biotherapies unlocking the muscle secretome to counter metabolic dysfunction. Our lead assets, based on human-centric discovery, preserve mitochondrial health, maintain tissue function and reduce chronic inflammation, addressing the unmet need in diabetes and MASH.

Alpinuity Bio aims to provide consulting services in the field of biopharmaceutical R&D specifically in translational science and biomarkers. We advise and support investors, start-ups and established companies in due diligence, scientific and technical aspects.  

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.